StockData
Starling Oncology, Inc. logo

Starling Oncology, Inc. (STLN) stock

STLNNasdaqServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31Also trades as DFPH, STLNW
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 7/30
$3.20−0.20 (-5.88%)

Close on Nov 18, 2026Market cap $326.13MP/E –Yield –

Starling Oncology price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Starling Oncology's price to sales ratio was 0.7× on Nov 11, 2026, against 0.7× a year earlier. Over the last 5 years it ranged from 0.0× to 3.2×, with a median of 0.5×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.7×−0.0
2025Dec 31, 20250.8×+0.7
2024Dec 31, 20240.1×−0.4
2023Dec 29, 20230.5×−0.0
2022Dec 30, 20220.5×–

More Starling Oncology figures

See a number that looks wrong?